29
Participants
Start Date
March 21, 2025
Primary Completion Date
April 24, 2028
Study Completion Date
April 24, 2029
Tarlatamab treatment
"* 1 mg step dose on cycle 1 day 1 (C1D1)~* 10 mg target dose on cycle 1 day 8 (C1D8), and cycle 1 day 15 (C1D15) in a 28-day cycle.~* 10 mg Q2W subsequently (i.e., C2 + D1/D15 dosing) in a 28-day cycle"
RECRUITING
University of California at Los Angeles, Los Angeles
NOT_YET_RECRUITING
UC San Diego Moores Cancer Center, San Diego
NOT_YET_RECRUITING
UCI Health Chao Family Comprehensive Cancer Center, Irvine
NOT_YET_RECRUITING
University of California at San Francisco, San Francisco
NOT_YET_RECRUITING
UC Davis Comprehensive Cancer Center, Davis
Collaborators (1)
Amgen
INDUSTRY
Jonsson Comprehensive Cancer Center
OTHER